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Oxidative stress has a critical role in the pathophysiology of several kidney diseases, and many complications of these diseases
are mediated by oxidative stress, oxidative stress-related mediators, and inﬂammation. Several systemic diseases such as
hypertension, diabetes mellitus, and hypercholesterolemia; infection; antibiotics, chemotherapeutics, and radiocontrast agents;
and environmental toxins, occupational chemicals, radiation, smoking, as well as alcohol consumption induce oxidative stress in
kidney. We searched the literature using PubMed, MEDLINE, and Google scholar with “oxidative stress, reactive oxygen species,
oxygen free radicals, kidney, renal injury, nephropathy, nephrotoxicity, and induction”. The literature search included only articles
written in English language. Letters or case reports were excluded. Scientiﬁc relevance, for clinical studies target populations, and
study design, for basic science studies full coverage of main topics, are eligibility criteria for articles used in this paper.
1.Introduction
Free radicals are chemical species with a single unpaired
electron, which is highly reactive as it seeks to pair with a
new free electron, and as a result of these reactions, other
free radicals or paired electrons occur and radical feature
may be lost. If newly formed free radical occurs, it is also
unstable and it can react with another molecule to produce
another free radical or a nonradical molecule occurs because
of the paired electrons of the newly formed molecule. Thus,
a chain reaction of free radicals occurs, leading to damaging
biological systems and tissues. In aerobic conditions, all
biological systems are exposed to oxidative stress (OS),either
generated internally or as by-products. The great majority
of these free radicals are mainly oxygen radicals and other
reactive oxygen species (ROS) [1].
The well-known ROS are superoxide ion (O2 •− ), hy-
drogen peroxide (H2O2),andperoxyl radical (OH•),and the
reactive nitrogen species (RNS) are nitric oxide (NO) and
peroxynitrite (ONOO−). Peroxynitrite generates from rapid
chemical interaction between NO and O2•−.M a i ns i t e so f
ROS produced in living organisms are mitochondrial elec-
tron transport system, peroxisomal fatty acid, cytochrome
P-450, and phagocytic cells [2–6]. Several extracellular and
intracellular factors such as hormones, growth factors,
proinﬂammatory cytokines, physical environmental factors
(like ultraviolet irradiation), nutrient metabolism, and the
detoxiﬁcation of various xenobiotics aﬀect production of OS
[7–13].
In physiological conditions, ROS produced in the course
of normal conditions are completely inactivated by cellular
and extracellular defence mechanisms. This means that
normally there is a balance between prooxidant (or oxidant)
and antioxidant defence systems. In certain pathological
conditions, increased generation of ROS and/or depletion
of antioxidant defence system leads to enhanced ROS
activity and OS, resulting tissue damage. OS causes tissue
damage by diﬀerent mechanisms including promoting lipid
peroxidation,DNAdamage,andproteinmodiﬁcation.These
processes have been implicated in the pathogenesis of several
systemic diseases including kidney.
Several systemic diseases such as hypertension, diabetes
mellitus,metabolicsyndrome,andhypercholesterolemia;in-
fection; antibiotics and chemotherapeutic agents, and radio-
contrast agents mainly excreted from kidney; and envi-
ronmental toxins especially heavy metals such as lead and
mercury,occupationalchemicalssuchasurbanﬁneparticles,
radiation, smoking, as well as alcohol consumption induce
renal OS. The kidney is an organ highly vulnerable to2 International Journal of Nephrology
damage caused by ROS, likely due to the abundance of long-
chain polyunsaturated fatty acids in the composition of renal
lipids. In recent years, OSs have become one of the most
popular topics in research of molecular mechanism of renal
diseases. The aim of this paper is to summarize the condi-
tions inducing OS in kidney and molecular mechanisms of
this induction and kidney damage.
2. DiabetesMellitusandInductionof
OxidativeStressinKidney
Recent years, diabetes and diabetic kidney disease continue
to increase worldwide. In the USA, diabetes-associated kid-
ney disease is a major cause of all new cases of end-stage
kidney disease. All diabetic patients are considered to be at
risk for nephropathy. Today we have not speciﬁc markers
to expect development of end-stage renal disease. Clinically
control of blood sugar level and blood pressure regulations
are important two parameters to the prevention of diabetic
nephropathy [14, 15].
There are huge amount of in vitro and in vivo studies
regarding explanation of mechanism of diabetes-mellitus-
induced nephropathy. All of these mechanisms are a conse-
quence of uncontrolled elevation of blood glucose level. Cur-
rentlytheproposedmechanismistheglomerularhyperﬁltra-
tion/hypertension hypothesis. According to this hypothesis,
diabetes leads to increased glomerular hyperﬁltration and
a resultant increased glomerular pressure. This increased
glomerular pressure leads to damage to glomerular cells
and to development of focal and segmental glomeruloscle-
rosis [16, 17]. Angiotensin II inhibitors reduce glomerular
pressure and prevent albuminuria. Increased angiotensin II
level induces OS through activation of NADPH oxidase,
stimulatinginﬂammatorycytokines,andsoforth...[18,19].
The mechanism by which hyperglycemia causes free
radical generation thus causes OS to be complex. Increased
blood glucose promotes glycosylation of circulator and
cellular protein and may initiate a series of autooxidation
reactions that culminate in the formation and accumulation
of advanced glycosylation end-products (AGEs) in tissues.
The AGEs have oxidizing potential and promote tissue
damage by oxygen-free radicals [20].
In experimental studies, formation of OS increases be-
cause of high level of blood glucose. Sadi et al. showed that
in diabetic rat kidney antioxidant enzyme, namely, catalase
(CAT) and glutathion peroxidase (GSHPx), activities were
found to be reduced; however, ∝-lipoic acid and vitamin C
administration increased these antioxidant enzyme activities
[21]. Increased OS is the common ﬁnding in tissues eﬀecting
from diabetes, including kidney. Reddi et al. showed that
transforming growth factor β1 (TGF-β1) is prooxidant and
Se (selenium) deﬁciency increases OS via this growth factor.
In addition Se deﬁciency may simulate hyperglycemic con-
ditions. Se supplementation to diabetic rats prevents for
formation of OS and renal structural injury [22]. Chen et
al. showed that nitrosative stress increases in diabetic rat
model [23]. These results show the induction of oxidative
and nitrosative stress in rat kidney. These may have a role
in pathophysiology of diabetes-induced morphological and
functional changes of kidney.
3. Hypertension, Hypercholesterolemia,
Obesity,andAging Induce Oxidative
Stress in Kidney
Hypertension is one of the major causes of development of
renal failure. Key regulator of this pathology is OS. Renal
artery stenosis is the most common cause of secondary
hypertension and may lead to deterioration of renal function
and ischemic nephropathy. Chade et al. showed that a
cross-talk between hypoperfusion and atherosclerosis to
interactively increased OS, inﬂammation, and tubular injury
in the stenotic kidney [24]. In experimental atherosclerotic
renovascular disease (simulated by concurrent hypercholes-
terolemia and renal artery stenosis), it was reported that
the activity of both CuZn and MnSOD isoforms was
signiﬁcantly decreased; however, protein expression of both
the NAD (P)H-oxidase subunits p67phox and p47phox,
nitrotyrosine, inducible nitric oxide synthase (iNOS), and
nuclear factor kappa-B (NFκB) increased. Furthermore,
tubular and glomerular protein expression of nitrotyrosine
is signiﬁcantly elevated [25]. Chronic blockade of OS with
antioxidant improves OS in kidney. All of these molecular
abnormalities suggest increased OS in rat kidney.
Noeman et al. showed that high-fat diet-induced obesity
isaccompaniedbyincreasedhepatic,cardiac,andrenaltissue
OS, which is characterized by reduction in the antioxidant
enzymes activities and glutathione levels, that correlate with
the increase in MDA and protein carbonyl (PCO) levels [26].
Increased cytokine release (inﬂammation-related cytokines
such as tumor necrosis factor-∝ and adiponectin) and renal
macrophage inﬁltration have been shown to contribute to
renal injury in models of obesity. Chow et al. reported
that monocyte chemoattractant protein-1 (MCP-1) is a
potent stimulator of macrophage recruitment. It is increased
in adipose tissue during obesity and in diabetic kidneys,
suggesting that inﬂammation of these tissues may be MCP-
1d e p e n d e n t[ 27]. Knight et al. also showed an increase in
renalmacrophage-speciﬁcCD68-positivestaininginamodel
of obesity and hypertension [28]. From these results, we
can say that macrophages are the source of increased OS
and renal injury in diabetes and obesity-induced renal
injury. Aging is associated with increased OS. Most of age-
dependent changes in the kidney such as excessive ﬁbrosis, a
general lack of regenerative ability, and an increase in apop-
tosis in cells that determine healthy renal functions are often
r e l a t e dt oe x c e s sO S[ 29]. At a molecular level, with aging
increased mutations in nuclear and mitochondrial DNA
(mtDNA), increased lipofuscin and AGEs, increased OS, and
increased apoptosis have been observed. Proximal tubular
cellscontainlargenumbersofmitochondriaandarethemost
reliant upon oxidative phosphorylation and most susceptible
to oxidant-induced apoptosis and mutations [30]. Recent
studies showed that antiaging gen, klotho, is important in
renal aging and OS-induced renal damage. The klotho gene
encodes the klotho protein, a single transmembrane proteinInternational Journal of Nephrology 3
of the beta-glycosidase family [31]. Mice overexpressing
klotho exhibit an extension in lifespan and resistance to oxi-
dative injury. Klotho is predominantly expressed in the
kidney, with its highest expression in cells of the distal con-
voluted tubule [32, 33]. Overexpression of klotho has been
found to enhance resistance to OS through the upregulation
of manganese superoxide dismutase (MnSOD). Yamamoto
et al. found that klotho modulates MnSOD in a FoxO-
dependent process [34]. MnSOD is found within the mito-
chondria where it acts as primary scavenger of oxidants.
4. UrinaryObstruction, Urolithiasis,
Infection, Ischemia Reperfusion Injury,
Transplantationof Kidney, andInduction
of OxidativeStress in Kidney
Most clinical and experimental studies have shown that OS
is increased in kidney and systemic circulation. Huang et al.
reported that the activities of catalase and manganese
superoxide dismutase were elevated in early stage of ethylene
glycol-induced urolithiasis model in rats; however, on day
42 almost all antioxidant enzyme activities were attenuated
except those of CAT. In this experiment, the possible mecha-
nism that causes free radical elevation in the kidney may be
diﬀerentinthecourseofethyleneglycol-inducedurolithiasis.
Initially systemic circulation may bring the toxic substances
to the kidney, and eventually these substances cause to pro-
duce free radicals. In the late stage progressive accumulation
of leucocytes and defective antioxidant enzyme activities
may cause kidney to remain under huge amount of OS
[35, 36]. In our experimental urolithiasis studies, we showed
decreased antioxidant enzyme activities and involvement of
NFκB and p38-MAPK (mitogen-activated protein kinase)
signaling pathways, related to OS in rat kidney [37–40]. In
invitrocellculturestudiesusingproximaltubularoriginline
derivedfrompigproximaltubules(LLC-PK1),andcollecting
duct origin Madin-Darby canine kidney (MDCK) cell lines,
it has been reported that calcium phosphate crystals cause
cellular injury by increasing ROS [41].
Today, extra corporeal shock wave lithotripsy (ESWL)
is widely used for the treatment of renal stones in selected
renal cases. In our work, we showed increased expression of
inducible NO synthase (iNOS) and NFκB, indirect evidence
of increased OS [42]. Recently, Gecit et al. showed that
ESWL treatment produces OS and causes impairment in the
antioxidant and trace element levels in the kidneys of rats
[43]. ESWL is associated with greater prevalence of hyper-
tension [44]. Ischemia insult and increased renal OS and
consequent endothelial dysfunction may be possible mech-
anism of hypertension after ESWL.
Urinary obstruction, especially ureteral obstruction due
to urolithiasis, is a common urological problem seen in
urology practice. Unilateral ureteral obstruction (UUO)
leadstodecreasedrenalMnSODandCATproteinexpression
in a time-dependent manner. Increased 4-hydroxynoneal (4-
HNE) stain for ROS products in the renal tubulointerstitial
compartment occurred after 4hr of UUO in the kidney. The
authors explain renal tubular apoptosis in UUO rat model
explained by increasing ROS in this study [45]. Various
markersofOSincreaseinUUOratkidneyssuchastheoxida-
tively damaged protein product Ne-carboxymethyl-lysine
(CML); the marker of DNA oxidant damage, 8-hydroxy-2  -
deoxyguanosine (8-OHdG)); and lipid peroxidation mark-
ers such as malondialdehyde (MDA), 8-iso prostaglandin
F2∝ (8-iPGF2∝), and 4-HNE or 4-hydroxy-hexenal (4-
HHE). OS response molecules like heat shock protein-70
(HSP-70), heat-shock protein-27, and heme oxygenase-1
(HO-1) [46–51] are strongly expressed after UUO. Mice
thataregeneticallydeﬁcientendogenousantioxidantenzyme
CAT are more susceptible to UUO-induced renal damage
than normal wild type mice. Furthermore, increased renal
concentrations of ROS have been observed in obstructed
kidneys, together with decreased activities of the major
protective antioxidant enzymes SOD, CAT, and glutathione
peroxidase [52, 53]. UUO-induced nephrotoxicity and renal
ﬁbrosis is thought to be secondary to increased OS in
kidney. In the literature there is some information about the
amelioration of antioxidant and reactive oxygen scavenger
agents against UUO-induced renal damage [54, 55]. For an
excellent detailed review, please refer to [56].
Infection is another inducer of OS in kidney. There are
a lot of experiments showing the increased oxidative stress
and decreased antioxidant defence mechanism, antioxidant
enzyme systems in kidney due to infection [57–60].
ROS are important mediators exerting toxic eﬀects
on various organs, including kidney during ischemia-
reperfusion (IR) injury. A large body of evidences indicate
the role of increased OS in the kidney and protective role
of antioxidants and ROS scavengers in IR injury-induced
nephropathy in the literature [61–63]. OS also has a role as
a mediator of injury in chronic allograft tubular atrophy and
interstitial ﬁbrosis in rat kidney [64]. Renal transplantation
is another OS inducer in kidney in human and animals.
OS increases in transplanted kidney because of pretransplant
and posttransplant conditions. If there is preexisting diseases
such as chronic kidney failure, inﬂammation, and diabetes
mellitus,kidneysaremoresensitivetoOSduringreperfusion
injury. Postoperative immunosuppressive agents are among
many risk factors inducing OS in kidney [65].
5.Antibiotics,Antineoplastic Agents,
Immunosuppressants,Analgesics,
Nonsteroidal AntiinﬂammatoryDrugs,
andRadiocontrast Agents Induce
OxidativeStress inKidney
Antibiotics, commonly used aminoglycosides, are nephro-
toxic agents. Their nephrotoxicity is mainly attributed to
induction of OS and depletion of antioxidat enzyme ac-
tivities in kidney. In our experiments, we showed that
iNOS/NFκB/p38MAPK pathway, OS taking place in this
axis, is involved in gentamicin-induced nephrotoxicity [66,
67]. Our and other studies showed the protective eﬀect of
anti oxidants and reactive oxygen scavenger agents against
gentamicin-induced nephrotoxicity [68–70].4 International Journal of Nephrology
Antineoplastic agents are commonly used for the treat-
ment of metastatic cancers. Some of these are nephrotoxic.
Excess ROS production and depressed antioxidant defence
mechanism are responsible from nephrotoxicity. Cisplatin is
the well-known and commonly used antineoplastic and
nephrotoxic agent. Other nephrotoxic anticancer agents are
carboplatin, methotrexate, doxorubicin, cyclosporine, and
adriamycin. Immunosuppressant such as sirolimus and cy-
closporine leads to nephrotoxicity via OS [71–80].
Cisplatin is one of the commonly used potent antitumor
drugs and cisplatin-based combination protocols are used as
front-line therapy for several human malignancies. Cisplatin
is toxic to the renal proximal tubules and dose dependent
[81, 82]. Several studies have reported the role of OS regard-
ing cisplatin-induced nephrotoxicity. Cisplatin is known to
accumulate in mitochondria of renal tubular epithelial cells
togetherwithROS;renaltubularcellmitochondrialdysfunc-
tion is also important in cisplatin-induced nephrotoxicity.
Mitochondria also continuously scavenge ROS via the action
of antioxidant enzymes such as SOD, GSHPx, CAT, and
glutathione S-transferase. Studies have demonstrated that
cisplatin induces ROS in renal epithelial cells primarily
by decreasing the activity of antioxidant enzymes and
by depleting intracellular concentrations of GSH. In vitro
studies using LLC-PK1 cells, which is characteristic of renal
proximal tubular epithelium, also showed the role of ROS in
cisplatin nephrotoxicity [83–89].
In this era, analgesics, especially paracetamol and
acetaminophen (APAP), and nonsteroidal antiinﬂammatory
drugs (NSAIDs) are widely used throught the world. Parac-
etamol and APAP are nephrotoxic drugs. Several in vitro
and in vivo studies showed that analgesics nephrotoxicity is
caused by increased ROS in kidney. Zhao et al. showed the
increased ROS, nitric oxide, and MDA levels, together with
depleted glutathione (GSH) concentration in the kidney of
rats. However, rhein, Chinese herb, can attenuate APAP-in-
duced nephrotoxicity in a dose-dependent manner [90]. We
showed in our experiment a signiﬁcant increase in MDA
and decreases in GSHPx, CAT, and SOD activities in APAP-
treated rat kidneys. These ﬁndings support the induction
of OS in rat kidney by APAP. Signiﬁcant beneﬁcial changes
were noted in serum and tissue OS indicators in rats treated
with strong antioxidant pineal hormone melatonin and
curcumin [91, 92] .G h o s he ta l .r e p o r t e di n c r e a s e dO S
and TNF-alpha production in rat tissues [93]. Efrati et al.
reported that diclofenac (NSAID) leads to nephrotoxicity by
increasing intrarenal ROS in rat kidney, and antioxidant, N-
acetylcysteine, prevents kidney damage [94].
Contrast-induced nephropathy (CIN) is a major clinical
concern, particularly with imaging procedures. CIN is the
third most common cause of acute kidney injury in hospi-
talized patients [95]. Experimental ﬁndings in vitro and in
vivo illustrate enhanced hypoxia and the formation of ROS
within the kidney following the administration of iodinated
contrast media, which may play a role in the development
of CIN. Studies indeed support this possibility, suggesting
ap r o t e c t i v ee ﬀect of ROS scavenging or reduced ROS
formation with the administration of N-acetyl cysteine and
bicarbonate infusion, respectively [96–99].
6. Alcohol, Smoking, EnvironmentalToxins,
Radiation,and MobilePhones Induce
OxidativeStress inKidney
Ethanol and its metabolites are excreted into urine, and its
content in the urine is higher than that of the blood and
the liver. Chronic alcohol administration decreases the renal
tubular reabsorption and reduces renal function. Functional
abnormalities of renal tubules may be associated with
ethanol-induced changes in membrane composition and
lipid peroxidation. Because of high content of long-chain-
polyunsaturated fatty acids, kidney is highly sensitive to OS
damage [100].
Recentlyitisreportedthatethanoladministrationcaused
a signiﬁcant decrease in the levels of antioxidant enzyme
CAT, SOD, and GSHPx activities and increases MDA in
kidney of the rats [101]. Shankar et al. showed that renal
metabolism of ethanol via Cytochrome P450 2E1 (CYP2E1)
and antidiuretic hormone-1 led to production of renal OS,
and activation of MAPK induces CYP24A1 resulting in
reducing circulating 1,25 (OH)2 D3 concentrations [102].
Pathogenesis of aldosterone/salt-induced renal injury simi-
larly is attributed to increased ROS and activation of MAPK
in rat kidney [103]. In other studies, authors showed that
chronic ethanol administration and cigarette smoke expo-
sure may cause renal injury by increasing oxidative and
nitrosative stress in rat kidney [104, 105].
Epidemiological studies have shown that smoking is an
accelerating risk factor for the development of nephropathy,
in which TGFβ1 plays a role in diabetic patients. Cell culture
studies using mesangial cell showed that smoking could
increase TGFβ1, probably due to increased oxidative stress
and PKCβ (protein kinase C beta) activation. This ﬁnding
supports the concept that smoking is a risk factor for
development of diabetic nephropathy by increasing OS in
kidney [106]. Similarly smoking and alcohol together in-
crease OS and suppress antioxidant defence mechanism in
kidney [104, 105].
In modern era, especially industrialised countries envi-
ronmental toxins such as air pollutions, substances in stored
foods, radiations, as well as heavy metals in waters especially
in underdeveloped countries are major health problem.
Ochratoxin A (OTA), a mycotoxin, produced by fungi
of improperly stored food products, has been linked to
the genesis of several disease states in both animals and
humans. It has been reported as nephrotoxic, carcinogenic,
teratogenic, immunotoxic, and hepatotoxic in laboratory
and domestic animals [107–109]. In primary rat kidney cells
andinvivoexperiments,ithasbeenshownthatOTAinduces
OS and depletes antioxidant systems. These events might
representpivotalfactorsinthechainofcellulareventsleading
into nephrotoxicity of OTA. Cadmium (Cd) is known to
be a widespread environmental contaminant and a potential
toxinthatmayadverselyaﬀectpublichealth.Cigarettesmoke
and food (from contaminated soil and water) are important
nonindustrial sources of exposure to Cd. Cd accumulates
in the kidney because of its preferential uptake by receptor-
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bound Cd (Cd-MT) in the proximal tubule. Internalised Cd-
MT is degraded in endosomes and lysosomes, releasing free
Cd into the cytosol, where it can generate ROS and activate
cell death pathways [110].
Another environmental nephrotoxic agent is diazi-
non (O,O-diethyl-O-[2-isopropyl-6-methyl-4-pyrimidinyl]
phosphorothioate). It is an organophosphate insecticide and
hasbeenusedworldwideinagricultureanddomesticforsev-
eral years. Shah et al. showed that diazinon exposure depletes
antioxidant enzymes and induces OS in rat kidney [111].
Increased air pollution as a result of industry is another
life threatening health problem. Boor et al. showed renal,
vascular,andcardiacﬁbrosisinratsexposedtopassivesmok-
ing and industrial dust ﬁbre amosite. Authors explain these
changes by increased OS in these tissues [112]. Nanosized
fraction of particulate air pollutions have been reported to
translocate from the airways into the bloodstream and act
on diﬀerent organs such as lungs, heart, liver, and kidneys.
Nemmar et al. examined the distribution and the patholog-
ical changes of diesel exhaust particles (DEPs) on systolic
blood pressure (SBP), systemic inﬂammation, oxidative
stress, and morphological alterations in lungs, heart, liver,
and kidneys in Wistar rats. They showed that DEPs cause
inﬂammation especially in lungs and pulmonary tissue, and
these pathological changes are attributed to increased OS
and inﬂammatory cytokines in these tissues [113]. Lead and
cadmium nephrotoxicity are also related to increased OS in
kidney [114, 115].
Radiation is an important inducer of OS. For diagnostic
and therapeutic purposes, radiation is commonly used.
Chronic OS after total body irradiation is thought to be the
cause of radiation nephropathy in rats. Authors looked for
evidence of OS after total-body irradiation in a rat model;
focusing on the period before that there is physiologically
signiﬁcant renal damage. No statistically signiﬁcant increase
in urinary 8-isoprostane (a marker of lipid peroxidation) or
carbonylated proteins (a marker of protein oxidation) was
foundovertheﬁrst42daysafterirradiation,whileasmallbut
statistically signiﬁcant increase in urinary 8-hydroxydeoxy-
guanosine (a marker of DNA oxidation) was detected at 35–
55 days. In renal tissues, they found no signiﬁcant increase
in either DNA or protein oxidation products over the ﬁrst
89 days after irradiation. They suggest that if chronic OS
is a part of the pathogenesis of radiation nephropathy,
it does not leave widespread or easily detectable evidence
behind. Emre et al. investigated the eﬀect of extremely low-
frequencyelectromagneticﬁeld(ELF-EMF)withpulsetrains
exposure on lipid peroxidation and hence oxidative stress in
the rat liver and kidney tissue. They found increases in the
levels of oxidative stress indicators, and the ﬂow cytometric
data suggested a possible relationship between the exposure
to magnetic ﬁeld and the cell death; however, there were
signiﬁcantly lower necrotic cell percentages in experimental
animals compared to either unexposed or sham control
groups [116]. These results suggest the inductive eﬀect of
radiation on OS in kidney.
For the last two decades, a large number of studies
have investigated the eﬀects of mobile phone radiation on
the human and animal. Cellular target and tissue damage
are diﬀerent. Male reproductive system is among the most
aﬀected system [117, 118]. Increased OS plays a central
role in radiofrequency-electromagnetic-waves- (RF-EMW-)
induced tissue damage. Devrim et al. examined the eﬀect of
RF-EMW on oxidant and antioxidant status in erythrocytes
and kidney, heart, liver, and ovary tissues from rats and
possible protective role of vitamin C. It was observed that
MDA level, xanthine oxydase (XO), and GSH-Px activities
signiﬁcantly increased in the EMR group as compared
with those of the control group in the erythrocytes. In
the kidney tissues, it was found that MDA level and CAT
activity signiﬁcantly increased, whereas XO and adenosine
deaminase (ADA) activities decreased in the cellular phone
groupascomparedwiththoseofthecontrolgroup.However,
in the heart tissues, it was observed that MDA level, ADA,
andXOactivitiessigniﬁcantlydecreasedinthecellularphone
group as compared with those of the control group. They
concluded that RF-EMR at the frequency generated by a cell
phone causes OS and peroxidation in the erythrocytes and
kidneytissuesfromrats.Intheerythrocytes,vitaminCseems
to make partial protection against the OS [119]. Ozguner
et al. reported similar results in rat experiments and they
also reported that preventive eﬀect of Caﬀeic acid phenethyl
ester(CAPE),aﬂavonoid-likecompound,isoneofthemajor
componentsofhoneybeepropolisandmelatoninagainstRF-
EMW-induced nephrotoxicity [120–122].
7. Conclusion
There is huge amount of literature concerning the link
between the OS and renal diseases. Systemic diseases such as
hypertension, diabetes mellitus, and hypercholesterolemia;
infection; antibiotics, chemotherapeutics, and radiocontrast
agents; and environmental toxins, occupational chemicals,
radiation, smoking, as well as alcohol consumption induce
renal OS. The kidney is a highly vulnerable organ to damage
caused by ROS, due to the abundance of long-chain-poly-
unsaturated fatty acids. Antioxidant and reactive oxygen
scavengers have been shown to be eﬀective in animals for
protecting kidney, but it is hard to translocate these results to
humans.Thismaybeduetoshortdurationofanimalstudies,
dose diﬀerences between animals and humans, and diﬀerent
pathophysiologic processes between animals and humans.
For understanding these steps, drugs will be developed to
alter the main process(es) responsible for increased OS. In
this paper, the conditions inducing OS in kidney and
molecular mechanisms of this induction and kidney damage
have been summarized. I hope that this paper will aid in
the understanding of this complex system and directing new
research eﬀort.
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